TrialAnnals of oncology : official journal of the European Society for Medical Oncology2008

Imatinib mesylate (Gleevec) in advanced breast cancer-expressing C-Kit or PDGFR-beta: clinical activity and biological correlations.

M Cristofanilli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.